Primary tumor location as a prognostic factor in metastatic colorectal cancer.
about
Advances in targeted and immunobased therapies for colorectal cancer in the genomic eraClinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database.Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer.PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational studyPerformance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers.Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients.A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.Association between mRNA expression of chemotherapy-related genes and clinicopathological features in colorectal cancer: A large-scale population analysisComparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: Results from the surveillance epidemiology and end results (SEER) database.Predictive effects of bilirubin on response of colorectal cancer to irinotecan-based chemotherapy.Is there a sex effect in colon cancer? Disease characteristics, management, and outcomes in routine clinical practice.Primary Tumor Location as a Predictive Factor for First-line Bevacizumab Effectiveness in Metastatic Colorectal Cancer Patients.The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysis.The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab EfficacyFrom tumour heterogeneity to advances in precision treatment of colorectal cancer.Current and future biomarkers in the treatment of colorectal cancer.Novel therapeutics in metastatic colorectal cancer: molecular insights and pharmacogenomic implications.Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies.Clinicopathological Associations of K-RAS and N-RAS Mutations in Indonesian Colorectal Cancer Cohort.The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer.Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location.Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer.Effect of primary tumor location and tumor size on the response to radiotherapy for liver metastases from colorectal cancer.Recent developments in the treatment of metastatic colorectal cancer.Expression analysis of microRNA as prognostic biomarkers in colorectal cancer.ESMO World Congress on Gastrointestinal Cancer.Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.Hyperuricemia at The Time Of Diagnosis is a Factor for Poor Prognosis in Patients With Stage II and III Colorectal Cancer (Uric Acid and Colorectal Cancer)What roles do colon stem cells and gap junctions play in the left and right location of origin of colorectal cancers?RE: Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer.Current and future biomarkers in colorectal cancer.CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy.DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers.Association of Primary Tumor Site With Mortality in Patients Receiving Bevacizumab and Cetuximab for Metastatic Colorectal Cancer.Does primary tumor location impact the prognosis of colorectal liver metastases patients after microwave ablation? - Lessons from 10 years' experience.The predictive effect of primary tumour location in the treatment of metastatic colorectal cancer: a Canadian consensus statement.Comprehensive genomic sequencing detects important genetic differences between right-sided and left-sided colorectal cancer.
P2860
Q26751344-8BA85546-5995-459B-A1E9-388AC5A50F29Q30313248-AAE3885F-54CD-4D3E-95EF-B575A60D4C63Q35836756-E440F0E1-51C7-417B-838C-B5429D392B29Q36050773-DBBE3BF6-8701-40BD-8777-BE8659DA9526Q36201032-229607E4-BAD5-450F-9DCA-FEF5B93CA911Q36218282-87A7AA88-1D49-4690-8454-A3082519D5BFQ36295303-CF214058-78A8-4139-AD8D-6E750D017A35Q36473730-02F6D4FE-C4D0-4755-BBBE-587B574BB0FCQ36545332-449DF6B4-FF21-4DDE-8C68-06E363B5AD7DQ36815039-FE2F76A7-765C-41BA-A630-45F295F0DFB6Q37672019-EFA3C34B-0223-4498-9BD0-3D1CB1B66444Q37675952-BEAE4E77-8233-422F-8ACC-25E35D85C51BQ38634905-1CD84209-2683-4D36-8274-E77CE7871BFAQ38668967-79A23884-B581-4F54-B213-A2CFBD7089BEQ38734344-782F6B3E-969F-4F5C-8D3D-88D2025F7EA8Q38786707-F8E49C60-E82A-4C74-B98A-71219D2E5A70Q38787244-FB9FDE85-421A-433E-BABF-BD51F1CCAE34Q38794338-05B69B43-044C-4984-AA73-4D9A15CCD798Q38816712-2AB07F2A-0749-4F0E-B9B0-8A63B0032079Q39065326-9B8C315D-0880-4F24-ABDA-75F7252E372EQ39238657-2CA6EC6C-FFB1-4B84-A58F-3F3B522EBAC2Q39703372-82AEB2AB-5A49-4641-9362-6B600FBB0713Q40428222-24736E55-5633-40D7-A2AB-B3ED69E6BDF8Q40757402-82D3413F-C399-4A7F-8688-559C92B278C0Q40978508-2A2E0F55-7E96-4381-B718-5DBF8A6D34C8Q41105389-6D6175CA-457B-491B-9506-330D46ADAE4EQ41592731-4E4A677F-8E92-40AB-B1B5-2372C9B54D40Q41655586-90B10E07-0AC2-47AE-835C-4355388E1554Q41835603-1776D887-C95B-461D-BE00-8422CC7D3E84Q42143944-7CCD00AC-E307-44C9-AD1D-1440FA6981F3Q42314685-DB2AB413-A239-4EDF-A44D-1068308633E7Q42873640-C4A1D4A0-99B3-41D7-80F6-4E0095B15426Q43492228-73D974FD-7B83-4AFE-927B-7F475DC383F3Q44582769-9509BA13-1757-44E1-9AB4-6A3BD249E986Q46181764-D759183F-09A3-4178-B54F-E2E6D248D547Q46185591-E38F436A-FCD7-4BD4-A08C-99F96D13F3C2Q46898020-E738EF47-3B86-46E9-9C49-7C7930E85B04Q47124374-51F77957-0A1B-4EB3-B9E3-A3E66E658E3DQ47142532-F71A93E4-FD6A-475D-ADE1-66BCA6BBBEACQ47145867-4918C3BE-B262-436F-9734-8AFBB6442202
P2860
Primary tumor location as a prognostic factor in metastatic colorectal cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Primary tumor location as a prognostic factor in metastatic colorectal cancer.
@ast
Primary tumor location as a prognostic factor in metastatic colorectal cancer.
@en
type
label
Primary tumor location as a prognostic factor in metastatic colorectal cancer.
@ast
Primary tumor location as a prognostic factor in metastatic colorectal cancer.
@en
prefLabel
Primary tumor location as a prognostic factor in metastatic colorectal cancer.
@ast
Primary tumor location as a prognostic factor in metastatic colorectal cancer.
@en
P2093
P2860
P50
P356
P1476
Primary tumor location as a prognostic factor in metastatic colorectal cancer
@en
P2093
Carlotta Antoniotti
Christiane Langer
Herbert I Hurwitz
Martin K H Maus
Shibao Feng
Stefan J Scherer
Thomas Müller
P2860
P356
10.1093/JNCI/DJU427
P407
P577
2015-02-24T00:00:00Z